Skip to content

Stereotaxis STXS Total Equity

Total Equity at other companies

Abbott logo
AbbottABT
$52.06B+6.7%
Boston Scientific logo
Boston ScientificBSX
$25.86B+16.4%
Medtronic logo
MedtronicMDT
$49.46B+3.0%
ITG
Integer HoldingsITGR
$1.7B+5.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$1.63B+13.9%
iRadimed logo
iRadimedIRMD
$98.51M+9.4%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's total equity?
Stereotaxis (STXS) reported total equity of $14.36M in Q1 2026.
How has Stereotaxis's total equity changed year-over-year?
Stereotaxis's total equity increased by 398.5% year-over-year, from $2.88M to $14.36M.
What is the long-term trend for Stereotaxis's total equity?
Over 5 years (2020 to 2025), Stereotaxis's total equity has grown at a -17.2% compound annual growth rate (CAGR), from $34.63M to $13.48M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.